Sign in
Taking people in South KoreaPhase 3

Tests a combined pill for high blood pressure and high cholesterol

Tests a combined drug treatment in adults with high blood pressure and high cholesterol.

Key facts

Who runs it
JW Pharmaceutical
Where
Seoul, South KoreaSee the site
Trial code
Registry title
Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Status
Recruiting
Phase
Phase 3
People taking part
162 people, planned
Started
2 Dec 2024
Planned end
Apr 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • JW0104+C2402
  • JW0104+C2403
  • C2402
Record updated
9 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with both high blood pressure and abnormal blood fats (dyslipidemia). It tests two medicines taken together.

Age
19 years or older
Sex
Men and women can join.
Disease stage
High blood pressure together with dyslipidemia. The blood pressure and LDL cholesterol levels must meet the levels set by the trial.
Biomarker or test result
Blood pressure (msBP) and LDL-C levels must meet the levels set by the trial.

Main reasons for not taking part

  • People whose blood pressure (msBP) and LDL-C levels do not meet the levels set by the trial cannot join.

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Patients with hypertension and dyslipidemia

Who cannot take part

  • The subject not meet the specified msBP and LDL-C level

Where in South Korea

  • Gangdong Sacred Heart HospitalSeoul, South KoreaContact: Minjung KimTaking people

About the trial

What the trial wants to find out

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia

The 3 groups in the trial

  • JW0104+C2402Treatment being tested

    JW0104+C2402, 8 weeks, QD (Quaque Die)

  • JW0104+C2403Existing treatment, for comparison

    JW0104+C2403, 8 weeks, QD

  • C2402Existing treatment, for comparison

    C2402, 8 weeks, QD

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Plain-language title
Tests a combined pill for high blood pressure and high cholesterolGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
9 September 2025